vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and VALHI INC (VHI). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $494.5M, roughly 1.7× VALHI INC). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs -10.8%, a 11.3% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 2.8%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -3.5%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Valhi, Inc. is an American holding company operating through wholly and majority-owned subsidiaries in a number of different industries. It was founded in 1987 as a result of the merger of the LLC Corporation and Amalgamated Sugar Company. The Contran Corporation owned 93% of Valhi's common stock as of December 2014. The chairman of the company was Harold Simmons until his death in 2013. As of 2014 it was a Fortune 1000 company.
ACHC vs VHI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $494.5M |
| Net Profit | $4.5M | $-53.2M |
| Gross Margin | — | 6.9% |
| Operating Margin | — | -6.2% |
| Net Margin | 0.5% | -10.8% |
| Revenue YoY | 7.5% | 2.8% |
| Net Profit YoY | -50.8% | -333.3% |
| EPS (diluted) | $0.05 | $-1.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $494.5M | ||
| Q3 25 | $851.6M | $503.5M | ||
| Q2 25 | $869.2M | $540.4M | ||
| Q1 25 | $770.5M | $538.6M | ||
| Q4 24 | $774.2M | $480.9M | ||
| Q3 24 | $815.6M | $533.6M | ||
| Q2 24 | $796.0M | $559.7M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $-53.2M | ||
| Q3 25 | $36.2M | $-22.2M | ||
| Q2 25 | $30.1M | $900.0K | ||
| Q1 25 | $8.4M | $16.9M | ||
| Q4 24 | $32.6M | $22.8M | ||
| Q3 24 | $68.1M | $57.5M | ||
| Q2 24 | $78.5M | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | 14.5% | ||
| Q1 25 | — | 22.7% | ||
| Q4 24 | — | 20.9% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 21.7% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | -6.2% | ||
| Q3 25 | 4.7% | 1.7% | ||
| Q2 25 | 5.8% | 6.6% | ||
| Q1 25 | 1.7% | 9.3% | ||
| Q4 24 | 4.9% | 11.8% | ||
| Q3 24 | 12.1% | 12.7% | ||
| Q2 24 | 13.4% | 9.8% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | -10.8% | ||
| Q3 25 | 4.3% | -4.4% | ||
| Q2 25 | 3.5% | 0.2% | ||
| Q1 25 | 1.1% | 3.1% | ||
| Q4 24 | 4.2% | 4.7% | ||
| Q3 24 | 8.4% | 10.8% | ||
| Q2 24 | 9.9% | 3.6% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $-1.86 | ||
| Q3 25 | $0.40 | $-0.78 | ||
| Q2 25 | $0.33 | $0.03 | ||
| Q1 25 | $0.09 | $0.59 | ||
| Q4 24 | $0.36 | $0.81 | ||
| Q3 24 | $0.74 | $2.01 | ||
| Q2 24 | $0.85 | $0.70 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $216.9M |
| Total DebtLower is stronger | $2.5B | $590.9M |
| Stockholders' EquityBook value | $2.0B | $1.0B |
| Total Assets | $5.5B | $2.6B |
| Debt / EquityLower = less leverage | 1.29× | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $216.9M | ||
| Q3 25 | $118.7M | $186.6M | ||
| Q2 25 | $131.4M | $190.9M | ||
| Q1 25 | $91.2M | $196.4M | ||
| Q4 24 | $76.3M | $350.2M | ||
| Q3 24 | $82.1M | $316.7M | ||
| Q2 24 | $77.2M | $386.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $590.9M | ||
| Q3 25 | $2.3B | $661.5M | ||
| Q2 25 | $2.3B | $544.8M | ||
| Q1 25 | $2.2B | $525.9M | ||
| Q4 24 | $2.0B | $484.4M | ||
| Q3 24 | $1.9B | $526.6M | ||
| Q2 24 | $1.8B | $497.4M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.0B | ||
| Q3 25 | $3.1B | $1.0B | ||
| Q2 25 | $3.1B | $1.1B | ||
| Q1 25 | $3.0B | $1.1B | ||
| Q4 24 | $3.1B | $1.0B | ||
| Q3 24 | $3.0B | $1.0B | ||
| Q2 24 | $3.0B | $962.6M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.6B | ||
| Q3 25 | $6.4B | $2.7B | ||
| Q2 25 | $6.3B | $2.8B | ||
| Q1 25 | $6.1B | $2.8B | ||
| Q4 24 | $6.0B | $2.8B | ||
| Q3 24 | $5.9B | $2.8B | ||
| Q2 24 | $5.7B | $2.5B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.58× | ||
| Q3 25 | 0.74× | 0.63× | ||
| Q2 25 | 0.74× | 0.51× | ||
| Q1 25 | 0.72× | 0.49× | ||
| Q4 24 | 0.64× | 0.47× | ||
| Q3 24 | 0.62× | 0.52× | ||
| Q2 24 | 0.62× | 0.52× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $100.6M |
| Free Cash FlowOCF − Capex | — | $89.8M |
| FCF MarginFCF / Revenue | — | 18.2% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-82.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $100.6M | ||
| Q3 25 | $73.2M | $-1.9M | ||
| Q2 25 | $133.5M | $21.7M | ||
| Q1 25 | $11.5M | $-155.9M | ||
| Q4 24 | $116.7M | $45.8M | ||
| Q3 24 | $163.1M | $13.5M | ||
| Q2 24 | $171.1M | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $89.8M | ||
| Q3 25 | $-63.0M | $-12.3M | ||
| Q2 25 | $-34.2M | $9.1M | ||
| Q1 25 | $-163.2M | $-168.7M | ||
| Q4 24 | $-86.8M | $33.3M | ||
| Q3 24 | $-27.1M | $3.9M | ||
| Q2 24 | $16.9M | $29.7M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 18.2% | ||
| Q3 25 | -7.4% | -2.4% | ||
| Q2 25 | -3.9% | 1.7% | ||
| Q1 25 | -21.2% | -31.3% | ||
| Q4 24 | -11.2% | 6.9% | ||
| Q3 24 | -3.3% | 0.7% | ||
| Q2 24 | 2.1% | 5.3% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.2% | ||
| Q3 25 | 16.0% | 2.1% | ||
| Q2 25 | 19.3% | 2.3% | ||
| Q1 25 | 22.7% | 2.4% | ||
| Q4 24 | 26.3% | 2.6% | ||
| Q3 24 | 23.3% | 1.8% | ||
| Q2 24 | 19.4% | 0.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | 24.11× | ||
| Q1 25 | 1.37× | -9.22× | ||
| Q4 24 | 3.58× | 2.01× | ||
| Q3 24 | 2.39× | 0.23× | ||
| Q2 24 | 2.18× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
VHI
| Chemicals | $418.3M | 85% |
| Real Estate Management And Development | $38.5M | 8% |
| Security Products | $29.5M | 6% |
| Marine Components | $8.2M | 2% |
